Organophosphorus poisoning can occur when one is exposed to organophosphates for too long or at high levels. Organophosphates are a common type of insecticide. However, high levels of organophosphates can be harmful to humans and other animals.
Organophosphates are useful as pharmaceuticals, pesticides, and as nerve agents. Due to the extensive usage of these chemicals in agriculture, the majority of organophosphate toxicity cases presently involve farmers and other individuals who function in this field.
Organophosphate molecules can penetrate the body through the skin, by inhalation, or through the digestive system
The molecule permeates red blood cells where it binds to an acetylcholinesterase molecule, making the enzyme inactive
This causes synapses and neuromuscular junctions to accumulate an excess of acetylcholine
Myoclonic jerks and fasciculations can occur as a result of the overstimulation of nicotinic receptors at neuromuscular junctions
The depolarizing blockage ultimately results in flaccid paralysis
The adrenal glands have nicotinic receptors, which can lead to hypertension, perspiration, tachycardia, and leukocytosis with a left shift
The effects of organophosphate poisoning on muscarinic receptors result in additional symptoms
G-protein-coupled receptors are responsible for these effects, which are typically slower than those of nicotinic receptors
Organophosphate toxicity has parasympathetic effects on several systems, including the heart, exocrine glands, and smooth muscles
Symptoms range from mild to moderate depending on the exposure to organophosphates, they include:
Mild organophosphate exposure results in:
Moderate organophosphate exposure results in:
Organophosphate poisoning can lead to several significant consequences. These are some examples:
1.
Even when they are not paying attention, children are still learning.
2.
Survivors of high-risk neuroblastoma face substantial late effects of modern therapies
3.
Kate Middleton Reaches Cancer Treatment Milestone
4.
Pulled Myeloma Drug Improves Survival in Trial
5.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.
1.
Breast Cancer Secrets: AI-Powered Precision Medicine
2.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
3.
Surprising Symptoms of Prostate Cancer: What You Need to Know
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation